Stephanie Oestreich
Corporate Officer/Principal chez GALECTO, INC.
Profil
Stephanie Oestreich is currently the Director of the Boston Philharmonic Orchestra.
She is also the Chief Business Officer at Galecto, Inc. since 2022 and the VP-Operations & Head-Alliance Management at Mnemo Therapeutics SAS.
Previously, she worked as the Executive Vice President at Evotec (US), Inc. and as a Principal at Orange Grove Bio LLC.
Dr. Oestreich holds a graduate degree from Harvard University and a doctorate from Freie Universität Berlin.
Postes actifs de Stephanie Oestreich
Sociétés | Poste | Début |
---|---|---|
GALECTO, INC. | Corporate Officer/Principal | 05/01/2022 |
Mnemo Therapeutics SAS
Mnemo Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Mnemo Therapeutics SAS is a French biotechnology company that develops cell therapies to create accessible cures for cancer patients. The company is based in Paris, FR, and has subsidiaries in the United States. The company applies a novel approach to cell therapy using its enfinit platform, a groundbreaking drug discovery engine. Mnemo is committed to addressing the challenges in the field of immuno-oncology, such as a lack of cancer-specific targets, long-term persistence, and sensitivity. The company aims to engineer the future of immunotherapies to transform the lives of people with cancer by discovering novel cancer-specific targets and boosting immune activity to treat solid tumors. The company was founded in 2019 by Alain Maïore and Michel Sadelain. Robert LaCaze has been the CEO of the company since 2022. | Corporate Officer/Principal | - |
Boston Philharmonic Orchestra
Boston Philharmonic Orchestra Movies/EntertainmentConsumer Services Boston Philharmonic Orchestra is a semi-professional orchestra. The company was founded by Benjamin Zander in 1979 and is headquartered in Boston, MA. | Director/Board Member | - |
Anciens postes connus de Stephanie Oestreich
Sociétés | Poste | Fin |
---|---|---|
Evotec (US), Inc. | Corporate Officer/Principal | - |
Orange Grove Bio LLC
Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Corporate Officer/Principal | - |
Formation de Stephanie Oestreich
Harvard University | Graduate Degree |
Freie Universität Berlin | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GALECTO, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Boston Philharmonic Orchestra
Boston Philharmonic Orchestra Movies/EntertainmentConsumer Services Boston Philharmonic Orchestra is a semi-professional orchestra. The company was founded by Benjamin Zander in 1979 and is headquartered in Boston, MA. | Consumer Services |
Evotec (US), Inc. | |
Mnemo Therapeutics SAS
Mnemo Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Mnemo Therapeutics SAS is a French biotechnology company that develops cell therapies to create accessible cures for cancer patients. The company is based in Paris, FR, and has subsidiaries in the United States. The company applies a novel approach to cell therapy using its enfinit platform, a groundbreaking drug discovery engine. Mnemo is committed to addressing the challenges in the field of immuno-oncology, such as a lack of cancer-specific targets, long-term persistence, and sensitivity. The company aims to engineer the future of immunotherapies to transform the lives of people with cancer by discovering novel cancer-specific targets and boosting immune activity to treat solid tumors. The company was founded in 2019 by Alain Maïore and Michel Sadelain. Robert LaCaze has been the CEO of the company since 2022. | Commercial Services |
Orange Grove Bio LLC
Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Finance |